Multiple Myeloma, New England Journal of Medicine, vol.351, issue.18, pp.1860-1873, 2004. ,
DOI : 10.1056/NEJMra041875
URL : https://hal.archives-ouvertes.fr/hal-00557757
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma, British Journal of Haematology, vol.86, issue.2, pp.158-164, 2006. ,
DOI : 10.1182/blood.V99.5.1745
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p, Blood, vol.119, issue.4, pp.940-948, 2012. ,
DOI : 10.1182/blood-2011-09-379164
Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report, Cancer Research, vol.64, issue.4, pp.1546-1558, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2876
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome, Blood, vol.109, issue.8, pp.3489-3495, 2007. ,
DOI : 10.1182/blood-2006-08-040410
Induction of angiogenesis by normal and malignant plasma cells, Blood, vol.114, issue.1, pp.128-143, 2009. ,
DOI : 10.1182/blood-2008-10-184226
URL : https://hal.archives-ouvertes.fr/inserm-00401390
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma, Blood, vol.113, issue.18, pp.4331-4340, 2009. ,
DOI : 10.1182/blood-2008-09-178350
URL : https://hal.archives-ouvertes.fr/inserm-00368414
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis, Oncogene, vol.83, issue.44, pp.3866-3879, 2009. ,
DOI : 10.1182/blood.V99.5.1745
URL : https://hal.archives-ouvertes.fr/inserm-00437705
Thymosin ??4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma, Haematologica, vol.95, issue.1, pp.163-167, 2010. ,
DOI : 10.3324/haematol.2009.006411
URL : https://hal.archives-ouvertes.fr/inserm-00453267
The molecular classification of multiple myeloma, Blood, vol.108, issue.6, pp.2020-2028, 2006. ,
DOI : 10.1182/blood-2005-11-013458
Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma, Journal of Clinical Oncology, vol.23, issue.26, pp.6333-6338, 2005. ,
DOI : 10.1200/JCO.2005.05.021
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma, Blood, vol.109, issue.11, pp.4914-4923, 2007. ,
DOI : 10.1182/blood-2006-08-043232
URL : https://hal.archives-ouvertes.fr/inserm-00136105
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells, Oncogene, vol.83, issue.21, pp.3512-3524, 2005. ,
DOI : 10.1038/sj.onc.1208536
URL : https://hal.archives-ouvertes.fr/inserm-00130206
Molecular Pathogenesis of Multiple Myeloma: Chromosomal Aberrations, Changes in Gene Expression, Cytokine Networks, and the Bone Marrow Microenvironment, Recent Results Cancer Res, vol.183, pp.39-86, 2011. ,
DOI : 10.1007/978-3-540-85772-3_3
Identification of genes modulated in multiple myeloma using genetically identical twin samples, Blood, vol.103, issue.5, pp.1799-1806, 2004. ,
DOI : 10.1182/blood-2003-02-0402
Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma, International Journal of Hematology, vol.102, issue.1, pp.177-185, 2009. ,
DOI : 10.1007/s12185-009-0356-8
Cloning and Characterization of the Annexin II Receptor on Human Marrow Stromal Cells, Journal of Biological Chemistry, vol.281, issue.41, pp.30542-30550, 2006. ,
DOI : 10.1074/jbc.M607072200
Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment, Blood, vol.119, issue.8, pp.1888-1896, 2012. ,
DOI : 10.1182/blood-2011-11-393348
The Role of Annexin II in Angiogenesis and Tumor Progression: A Potential Therapeutic Target, Current Pharmaceutical Design, vol.13, issue.35, pp.3568-3575, 2007. ,
DOI : 10.2174/138161207782794167
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo, Journal of Clinical Investigation, vol.113, issue.1, pp.38-48, 2004. ,
DOI : 10.1172/JCI19684
The role of annexin 2 in osteoblastic mineralization, Journal of Cell Science, vol.117, issue.3, pp.441-449, 2004. ,
DOI : 10.1242/jcs.00909
Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures, Journal of Clinical Investigation, vol.103, issue.11, pp.1605-1613, 1999. ,
DOI : 10.1172/JCI6374
Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast ,
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma, Leukemia, vol.63, issue.5, pp.1079-1088, 2007. ,
DOI : 10.1038/sj.leu.2404621
URL : https://hal.archives-ouvertes.fr/inserm-00270565
Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells, Experimental Cell Research, vol.316, issue.11, pp.1816-1828, 2010. ,
DOI : 10.1016/j.yexcr.2010.03.013
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood, Experimental Hematology, vol.33, issue.11, pp.1402-1416, 2005. ,
DOI : 10.1016/j.exphem.2005.07.003
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma, Leukemia, vol.19, issue.2, pp.275-278, 2005. ,
DOI : 10.1038/sj.leu.2403586
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays, Journal of the American Statistical Association, vol.99, issue.468, pp.909-917, 2004. ,
DOI : 10.1198/016214504000000683
Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, vol.8, issue.1, pp.118-127, 2007. ,
DOI : 10.1093/biostatistics/kxj037
PANP - a New Method of Gene Detection on Oligonucleotide Expression Arrays, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering, pp.108-115, 2007. ,
DOI : 10.1109/BIBE.2007.4375552
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments, Statistical Applications in Genetics and Molecular Biology, vol.3, issue.1, p.3, 2004. ,
DOI : 10.2202/1544-6115.1027
Controlling the false discovery: a practical and powerful approach to multiple testing, J R Stat Soc Series B, vol.57, pp.289-300, 1995. ,
Bioconductor: open software development for computational biology and bioinformatics, Genome Biology, vol.5, issue.10, p.80, 2004. ,
DOI : 10.1186/gb-2004-5-10-r80
The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma, New England Journal of Medicine, vol.349, issue.26, pp.2483-2494, 2003. ,
DOI : 10.1056/NEJMoa030847
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor, Blood, vol.113, issue.19, pp.4614-4626, 2009. ,
DOI : 10.1182/blood-2008-07-170464
URL : https://hal.archives-ouvertes.fr/inserm-00367812
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis, The Journal of Pathology, vol.22, issue.5, pp.673-685, 2006. ,
DOI : 10.1002/path.1935
Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression, Experimental and Molecular Pathology, vol.81, issue.2, pp.146-156, 2006. ,
DOI : 10.1016/j.yexmp.2006.03.003
Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration, Oncogene, vol.22, issue.10, pp.1475-1485, 2003. ,
DOI : 10.1038/sj.onc.1206196
Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer, Journal of Cellular Biochemistry, vol.278, issue.Pt 3, pp.370-380, 2008. ,
DOI : 10.1002/jcb.21835